You are searching for: hsa04015

---

T14853 Target Info	Target Name	Fibroblast growth factor-23 (FGF23)
	Target type	Successful Target
	Disease	X-linked hypophosphataemia;
	Drugs	Burosumab	Drug Info

T35940 Target Info	Target Name	ERK activator kinase 1 (MEK1)
	Target type	Clinical trial Target
	Disease	Melanoma; Thyroid cancer;
	Drugs	Selumetinib	Drug Info

T91331 Target Info	Target Name	Fibroblast growth factor receptor 3 (FGFR3)
	Target type	Successful Target
	Disease	Cholangiocarcinoma; Coronary artery disease;
	Drugs	Pemigatinib	Drug Info

T67619 Target Info	Target Name	RAC-alpha serine/threonine-protein kinase (AKT1)
	Target type	Successful Target
	Disease	Triple negative breast cancer; Colorectal cancer;
	Drugs	Capivasertib	Drug Info

T63966 Target Info	Target Name	Vascular endothelial growth factor receptor 1 (FLT-1)
	Target type	Successful Target
	Disease	Renal cell carcinoma; Neuroendocrine cancer;
	Drugs	Tivozanib	Drug Info

T92144 Target Info	Target Name	Angiopoietin 1 receptor (TEK)
	Target type	Clinical trial Target
	Disease	Peripheral arterial disease; Diabetic macular edema;
	Drugs	AKB-9778	Drug Info

T89055 Target Info	Target Name	ERK activator kinase 2 (MEK2)
	Target type	Clinical trial Target
	Disease	Melanoma; Thyroid cancer;
	Drugs	Selumetinib	Drug Info

T58970 Target Info	Target Name	Extracellular signal-regulated kinase 2 (ERK2)
	Target type	Clinical trial Target
	Disease	Melanoma; Artery stenosis;
	Drugs	BVD-523	Drug Info

T71266 Target Info	Target Name	RAC-gamma serine/threonine-protein kinase (AKT3)
	Target type	Successful Target
	Disease	Breast cancer; Triple negative breast cancer;
	Drugs	Capivasertib	Drug Info

T65864 Target Info	Target Name	Stress-activated protein kinase 2a (p38 alpha)
	Target type	Clinical trial Target
	Disease	Xerophthalmia; Acute coronary syndrome;
	Drugs	Ozagrel	Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.